期刊文献+

沙格列汀对高糖环境下成骨细胞增殖、分化和凋亡的影响 被引量:4

Effects of saxagliptin on proliferation,differentiation,and apoptosis of osteoblasts in high glucose environment
下载PDF
导出
摘要 目的观察沙格列汀对高糖环境下成骨细胞增殖、分化和凋亡的影响,为糖尿病性骨质疏松患者选择合理的降糖药物提供理论依据。方法取成骨细胞MC3T3-E1置于a-MEM培养基中常规培养、传代。取传3代的对数生长期细胞,随机分为正常对照组、高糖组、高糖联合沙格列汀组,即刻更换a-MEM培养基,正常对照组更换为葡萄糖浓度5.5 mmol/L的培养液,高糖组更换为葡萄糖浓度30.0 mmol/L的培养液,高糖联合沙格列汀组更换为葡萄糖浓度30.0 mmol/L+沙格列汀1μmol/L的培养液,继续培养48 h。收集各组细胞,分别采用CCK-8法和流式细胞术检测细胞增殖能力和细胞凋亡率,ELISA法检测碱性磷酸酶(ALP)活性,qRT-PCR法检测成骨细胞分化相关基因Ⅰ型胶原(COL-Ⅰ)、成骨特异性转录因子2(Runx2)、骨钙蛋白(OCN)、骨桥蛋白(OPN)mRNA表达。结果与正常对照组比较,高糖组、高糖联合沙格列汀组细胞增殖能力、ALP活性及成骨细胞分化相关基因COL-Ⅰ、Runx2、OCN、OPN mRNA相对表达量均明显降低,细胞凋亡率均明显升高(P均<0.05);与高糖组比较,高糖联合沙格列汀组细胞增殖能力、ALP活性和成骨细胞分化相关基因COL-Ⅰ、Runx2、OCN、OPN mRNA相对表达量均明显升高,细胞凋亡率均明显降低(P均<0.05)。结论沙格列汀能在一定程度上逆转高糖环境对小鼠成骨细胞增殖、分化和凋亡的影响,为糖尿病性骨质疏松患者的降糖治疗提供了理论依据。 Objective To investigate the effects of saxagliptin on the proliferation,differentiation,and apoptosis of osteoblasts in high glucose environment,so as to provide the theoretical basis for the selection of rational hypoglycemic agents for patients with diabetic osteoporosis. Methods Osteoblasts MC3T3-E1 were cultured and passaged in a-MEM medium. The cells of 3 generations in the logarithmic phase were randomly divided into the normal control group,high glucose group,and high glucose + saxagliptin group. The a-MEM medium was immediately replaced with 5. 5 mmol/L glucose medium in the normal control group,the a-MEM medium was immediately replaced with 30. 0 mmol/L glucose medium in the high glucose group,and the a-MEM medium was immediately replaced with 30. 0 mmol/L glucose + 1 μmol/L saxagliptin medium in the high glucose + saxagliptin group. MC3T3-E1 osteoblasts were then cultured in different culture mediums for48 h. CCK-8 method and flow cytometry were used to detect the proliferation ability and apoptosis rate,ELISA assay was used to detect alkaline phosphatase( ALP) activity,and qRT-PCR was used to detect the mRNA expression of COL-Ⅰ,Runx2,OCN and OPN. Results Compared with the normal control group,the proliferation,ALP activity and expression of COL-ⅠmRNA,Runx2 mRNA,OCN mRNA,and OPN mRNA were significantly decreased,and the apoptosis rate was significantly increased in the high glucose group and high glucose + saxagliptin group( all P〈0. 05). Compared with the high glucose group,the proliferation,ALP activity and expression of COL-Ⅰ mRNA,Runx2 mRNA,OCN mRNA,and OPN mRNA were significantly increased,and the apoptosis rate was significantly decreased in the high glucose + saxagliptin group( all P〈0. 05). Conclusion Saxagliptin can reverse the effects of high glucose environment on proliferation,differentiation,and apoptosis of MC3T3-E1 osteoblasts to a certain extent,which can be used for hypoglycemic therapy for patients with diabetic osteoporosis.
出处 《山东医药》 CAS 北大核心 2017年第28期16-19,共4页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81400788)
关键词 糖尿病性骨质疏松症 沙格列汀 成骨细胞 细胞增殖 细胞分化 细胞凋亡 diabetic osteoporosis saxagliptin osteoblasts cell proliferation cell differentiation apoptosis
  • 相关文献

参考文献3

二级参考文献26

  • 1Bipradas Roy.Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures[J].World Journal of Diabetes,2013,4(4):101-113. 被引量:42
  • 2王维皓,王智民.姜的化学、药理研究进展[J].中国中药杂志,2005,30(20):1569-1573. 被引量:34
  • 3肖元元, 徐淼, 刘若冰,等. 肝细胞脂肪性病变对胰高血糖素样肽1受体表达的影响[J]. 中华临床医师杂志(电子版), 2013,7(22):10118-10123. 被引量:2
  • 4Salehi M, Aulinger BA, D'Alessio DA. Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins [J]. Endocr Rev, 2008,29(3 ) :367-379. DOI: 10. 1210/er. 2007- 0031. 被引量:1
  • 5Noyan-Ashraf MH, Momen MA, Ban K, et al. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice [ J ]. Diabetes, 2009,58 (4) :975-983. DOI: 10. 2337/db08-1193. 被引量:1
  • 6Okerson T, Yan P, Stonehouse A, et al. Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes [ J ]. Am J Hypertens, 2010,23 ( 3 ) :334-339. DOI : 10. 1038/ajh. 2009. 245. 被引量:1
  • 7Ishibashi Y, Nishino Y, Matsui T, et al. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level [ J ]. Metabolism, 2011, 60(9 ) : 1271-1277. DOI: 10. 1016/j. lnetabol. 2011.01. 010. 被引量:1
  • 8Mieczkowska A, Mansur S, Bouvard B, et al. Double incretin receptor knock-out ( DIRKO ) mice present with alterations of trabecular and cortical micromorphology and bone strength [J]. Osteoporos Int, 2015, 26( I ) :209-218. DOI: 10. 1007/s00198)14-2845-8. 被引量:1
  • 9Yamada C, Yamada Y, Tsukiyama K, et al. The murine glucagon-like peptide-I receptor is essential for control of bone resorption [ J ]Endocrinology, 2008,149 (2) : 574-579. DOI: 10. 1210/en. 2007- 1292. 被引量:1
  • 10Sanz C, V6zquez P, Bl6zquez C, et al. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow [ J ]. Am J Physiol Endocrinol Metab, 2010,298 ( 3 ) : E634-E643. DOI : 10.1152/ajpendo. 00460. 2009. 被引量:1

共引文献9

同被引文献41

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部